Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Shares Issued (2016 - 2025)

HealthLynked (HLYK) has disclosed Shares Issued for 10 consecutive years, with $10000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Shares Issued fell 97.18% to $10000.0 in Q1 2025 year-over-year; TTM through Sep 2025 was $10000.0, a 98.72% decrease, with the full-year FY2024 number at $405000.0, down 52.35% from a year prior.
  • Shares Issued was $10000.0 for Q1 2025 at HealthLynked, down from $50000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $6.7 million in Q3 2021 to a low of -$6.6 million in Q4 2021.
  • A 5-year average of $213498.9 and a median of $239150.5 in 2021 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 1676.61% in 2021; the steepest drop was 7600.15% in 2021.
  • HealthLynked's Shares Issued stood at -$6.6 million in 2021, then soared by 103.79% to $250000.0 in 2022, then skyrocketed by 50.0% to $375000.0 in 2023, then crashed by 86.67% to $50000.0 in 2024, then plummeted by 80.0% to $10000.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Shares Issued are $10000.0 (Q1 2025), $50000.0 (Q2 2024), and $355000.0 (Q1 2024).